Strategies for Selecting the Optimal Treatment in Newly Diagnosed Multiple Myeloma Patients

Steinbach, Mary; Richards, Tiffany; Faiman, Beth

doi:10.1016/j.soncn.2017.05.003

Cited by 3 publications

(2 citation statements)

References 78 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The use of stem cell transplantation, chemotherapy, immunomodulatory agents, and other drugs has also been reviewed in the literature. [19][20][21] Orthopaedic surgical intervention is reserved for patients with pathologic fractures, impending fractures of the long bones, vertebral column instability, as well as for the secondary effects of osteolytic lesions such as joint degeneration (when life expectancy is > 3 months). 16,22 Surgical intervention is generally well tolerated and may improve survival time.…”

Section: Multiple Myelomamentioning

confidence: 99%

Metastatic Disease, Myeloma, and Lymphoma Affecting the Hip

et al. 2019

View full text Add to dashboard Cite

The three most common causes for bony lesions in patients over 40 years of age are metastatic disease, multiple myeloma, and lymphoma. Oftentimes, these conditions have a predilection for the hip region. The authors present the incidence, characteristics, and treatment of metastatic disease, multiple myeloma, and lymphoma affecting the hip joint to help clinicians accurately diagnose and manage these conditions. They also present the senior author's technique of cemented long stem hemiarthroplasty for treating these conditions when they affect the proximal femur.

show abstract

Section: Multiple Myelomamentioning

confidence: 99%

Metastatic Disease, Myeloma, and Lymphoma Affecting the Hip

et al. 2019

View full text Add to dashboard Cite

show abstract

“…The average survival time is about 3-4 years, and only 20% of patients survive over 5 years [2,10]. Rapid diagnosis, appropriate selection of treatment procedures and control of the obtained effects improve the prognosis of patients and reduce the risk of possible disease recurrence [12]. Several factors such as age, general health, laboratory and cytogenetic test results, and the symptoms and complications of the disease can affect the treatment of multiple myeloma.…”

Section: Introductionmentioning

confidence: 99%

In-hospital rehabilitation in the treatment of multiple myeloma

Mińko

Szczypiór-Piasecka

Kotrych

2021

J Educ Health Sport

View full text Add to dashboard Cite

Wprowadzenie: Szpiczak mnogi (MM) jest jednym z najczęstszych złośliwych nowotworów kości. Podstawową procedurą leczenia szpiczaka mnogiego jest chemioterapia połączona z autologicznym przeszczepem komórek macierzystych. Leczenie operacyjne, polegające na wycięciu guza, jest wskazane, gdy istnieje ryzyko patologicznego złamania kości lub ucisku guza na korzenie nerwowe. Konieczne jest stworzenie indywidualnego planu leczenia we współpracy interdyscyplinarnej. Ważnym elementem leczenia jest pomoc w zakresie rehabilitacji. Celem pracy było wskazanie procedur rehabilitacyjnych w leczeniu szpiczaka mnogiego po rekonstrukcji endoprotezy w okresie szpitalnym.Materials and methods: The work was written based on the medical history of a patient diagnosed with multiple myeloma in the proximal part of the right femur. The entire treatment procedure was carried out at the Department of Orthopedics, Traumatology and Oncology of the Musculoskeletal System, located at Unii Lubelskiej 1 in Szczecin.Results: Rehabilitation in the treatment process of patients after resection of the tumor in the proximal part of the femur and arthroplasty is implemented as early as 1 day after the surgery in order to activate the patient as soon as possible. The rehabilitation program was as individualized as possible to the patient and included modern techniques such as osteopathy and manulana therapy.Wniosek: Rehabilitacja jest nieodzownym elementem leczenia chorych na nowotwory. Wprowadzenie do rehabilitacji nowoczesnych technik wpływa pozytywnie na skuteczność terapii. Wczesne rozpoczęcie rehabilitacji przynosi wymierne korzyści w trakcie leczenia i powrót pacjenta do aktywnego udziału w życiu społecznym.

show abstract